Resilience Among Individuals With Opioid Use Disorder
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT06954402
- Status
- Recruiting
Conditions
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Acute Stress Intervention (MAST-based) — BEHAVIORALThis intervention uses the Maastricht Acute Stress Test (MAST) to induce an acute stress response. Participants are exposed to standardized stress tasks while performing laboratory-based assessments of cognitive, emotional, and control aspects of resilience.
- Non-Stress Intervention (NST-based) — BEHAVIORALIn this control intervention, participants complete the same battery of laboratory tasks without exposure to the acute stressor.
Study Details
The goal of this clinical trial is to develop a human laboratory model of resilience in people with opioid use disorder (OUD). The investigators aim to learn if objective tasks that measure cognitive, emotional, and control aspects of resilience match up with self-reported resilience during stress and non-stress situations.
Key Dates
- Start date
- May 29, 2026
- Status verified
- May 2026
- Primary completion
- Apr 30, 2029
- Completion
- Apr 30, 2029
Study Design
- Enrollment
- 125 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Stress-First SequenceParticipants in this arm will first undergo the stress condition using the Maastricht Acute Stress Test (MAST) and then complete the non-stress condition (NST) in a subsequent session.
- Experimental: Non-Stress-First SequenceParticipants in this arm will first complete the non-stress condition (NST) and then undergo the stress condition using the Maastricht Acute Stress Test (MAST) in a subsequent session.
Primary Outcome Measure
Self-Reported Trait Resilience as assessed by Connor-Davidson Resilience Scale 25 (CD-RISC-25) [ Time Frame: Immediately after completing the task ]
Central Contacts
- Suky Martinez, PhD410-550-0007
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins University Bayview Medical Campus | Baltimore | Maryland | 21224 | - |
| Johns Hopkins University Bayview Medical Campus | Baltimore | Maryland | 21224 |
Find similar trials in Baltimore, MD
By research site
Related Studies
- Assessing a Clinically-meaningful Opioid Withdrawal PhenotypePHASE2 · Recruiting · University of Maryland, Baltimore · Baltimore, Maryland
- Developing a Clinical Outcome Assessment for Opioid CravingRecruiting · Johns Hopkins University · Baltimore, Maryland
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use FentanylPHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Divided or Single Exposure (DOSE) StudyPHASE2/PHASE3 · Recruiting · University of Maryland, Baltimore · Baltimore, Maryland